Mark H. Einstein

1.7k total citations
32 papers, 1.2k citations indexed

About

Mark H. Einstein is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology. According to data from OpenAlex, Mark H. Einstein has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Obstetrics and Gynecology, 12 papers in Reproductive Medicine and 10 papers in Oncology. Recurrent topics in Mark H. Einstein's work include Endometrial and Cervical Cancer Treatments (17 papers), Ovarian cancer diagnosis and treatment (12 papers) and Cervical Cancer and HPV Research (5 papers). Mark H. Einstein is often cited by papers focused on Endometrial and Cervical Cancer Treatments (17 papers), Ovarian cancer diagnosis and treatment (12 papers) and Cervical Cancer and HPV Research (5 papers). Mark H. Einstein collaborates with scholars based in United States, Canada and Rwanda. Mark H. Einstein's co-authors include Gary L. Goldberg, Howard D. Strickler, Gloria S. Huang, Nicole Nevadunsky, Gurpreet Kaur, Alyson B. Moadel, Anne Van Arsdale, Juliana Gebb, Arthee Jahangir and Wilber Quispe‐Tintaya and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and American Journal of Obstetrics and Gynecology.

In The Last Decade

Mark H. Einstein

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark H. Einstein United States 17 536 367 362 357 209 32 1.2k
Christopher S. Awtrey United States 16 245 0.5× 416 1.1× 442 1.2× 229 0.6× 218 1.0× 31 1.3k
Sarah Kitson United Kingdom 19 472 0.9× 268 0.7× 286 0.8× 271 0.8× 239 1.1× 31 945
Rachel W. Miller United States 15 253 0.5× 208 0.6× 515 1.4× 238 0.7× 237 1.1× 54 959
Amer Karam United States 19 274 0.5× 333 0.9× 301 0.8× 445 1.2× 182 0.9× 61 1.3k
Mike F. Janicek United States 16 252 0.5× 247 0.7× 248 0.7× 198 0.6× 117 0.6× 24 847
Vicki V. Baker United States 22 418 0.8× 498 1.4× 299 0.8× 442 1.2× 160 0.8× 62 1.6k
Aliza Leiser United States 13 213 0.4× 433 1.2× 301 0.8× 335 0.9× 404 1.9× 29 1.2k
Kristin Bixel United States 16 366 0.7× 155 0.4× 423 1.2× 254 0.7× 96 0.5× 70 872
Radoslav Chekerov Germany 20 295 0.6× 327 0.9× 698 1.9× 413 1.2× 208 1.0× 105 1.3k
Juhani Mäenpää Finland 17 289 0.5× 175 0.5× 305 0.8× 201 0.6× 137 0.7× 75 943

Countries citing papers authored by Mark H. Einstein

Since Specialization
Citations

This map shows the geographic impact of Mark H. Einstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Einstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Einstein more than expected).

Fields of papers citing papers by Mark H. Einstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark H. Einstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Einstein. The network helps show where Mark H. Einstein may publish in the future.

Co-authorship network of co-authors of Mark H. Einstein

This figure shows the co-authorship network connecting the top 25 collaborators of Mark H. Einstein. A scholar is included among the top collaborators of Mark H. Einstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark H. Einstein. Mark H. Einstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Merritt, Melissa A., Howard D. Strickler, Mark H. Einstein, et al.. (2016). Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors. Cancer Causes & Control. 27(6). 737–748. 32 indexed citations
4.
Einstein, Mark H., et al.. (2015). Menopause and Cancers. Endocrinology and Metabolism Clinics of North America. 44(3). 603–617. 9 indexed citations
5.
Nathan, Lisa, et al.. (2015). Decentralizing Maternity Services to Increase Skilled Attendance at Birth and Antenatal Care Utilization in Rural Rwanda: A Prospective Cohort Study. Maternal and Child Health Journal. 19(9). 1949–1955. 17 indexed citations
6.
Nevadunsky, Nicole, Anne Van Arsdale, Howard D. Strickler, et al.. (2015). Association Between Statin Use and Endometrial Cancer Survival. Obstetrics and Gynecology. 126(1). 144–150. 38 indexed citations
7.
Nevadunsky, Nicole, Anne Van Arsdale, Howard D. Strickler, et al.. (2014). Obesity and Age at Diagnosis of Endometrial Cancer. Obstetrics and Gynecology. 124(2). 300–306. 79 indexed citations
8.
Straten, Ariane van der, Helen Cheng, Barbara Mensch, et al.. (2013). Evaluation of 3 Approaches for Assessing Adherence to Vaginal Gel Application in Clinical Trials. Sexually Transmitted Diseases. 40(12). 950–956. 12 indexed citations
9.
Hou, June Y., Santiago Aparo, Mohammad H. Ghalib, et al.. (2013). Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: A single institution experience from 1999 to 2010. Gynecologic Oncology. 131(1). 163–168. 6 indexed citations
10.
Chandra, Dinesh, Arthee Jahangir, Wilber Quispe‐Tintaya, Mark H. Einstein, & Claudia Gravekamp. (2013). Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice. British Journal of Cancer. 108(11). 2281–2290. 113 indexed citations
11.
Herzog, Thomas J., Deborah K. Armstrong, Mark F. Brady, et al.. (2013). Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper. Gynecologic Oncology. 132(1). 8–17. 48 indexed citations
12.
Hou, June Y., David Smotkin, Robert Grossberg, et al.. (2012). High Prevalence of High Grade Anal Intraepithelial Neoplasia in HIV-Infected Women Screened for Anal Cancer. JAIDS Journal of Acquired Immune Deficiency Syndromes. 60(2). 169–172. 15 indexed citations
13.
Smotkin, David, et al.. (2012). Histopathologic differences account for racial disparity in uterine cancer survival. Gynecologic Oncology. 127(3). 616–619. 32 indexed citations
14.
Einstein, Mark H., Marina Frimer, D.Y.S. Kuo, et al.. (2011). Phase II trial of adjuvant pelvic radiation “sandwiched” between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma. Gynecologic Oncology. 124(1). 21–25. 41 indexed citations
15.
Blank, Stephanie V., Paul J. Christos, Mimi Kim, et al.. (2009). Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: A New York Cancer Consortium Study. Gynecologic Oncology. 116(3). 442–446. 16 indexed citations
16.
Novetsky, Akiva P., Mark H. Einstein, Gary L. Goldberg, et al.. (2007). Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer. Gynecologic Oncology. 105(3). 635–640. 24 indexed citations
17.
Huang, Gloria S., Juliana Gebb, Mark H. Einstein, et al.. (2007). Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors. American Journal of Obstetrics and Gynecology. 196(3). 243.e1–243.e5. 94 indexed citations
18.
Huang, Gloria S., Juliana Gebb, Marc J. Gunter, et al.. (2007). Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma. Gynecologic Oncology. 107(3). 513–517. 51 indexed citations
19.
Einstein, Mark H., Akiva P. Novetsky, Madhur Garg, et al.. (2006). Survival and toxicity differences between 5‐day and weekly cisplatin in patients with locally advanced cervical cancer. Cancer. 109(1). 48–53. 15 indexed citations
20.
Goel, Sanjay, Kavita Desai, Imran Chaudhary, et al.. (2006). Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers. Investigational New Drugs. 25(3). 237–245. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher S. Awtrey Breakdown of academic impact, for papers by Sarah Kitson Breakdown of academic impact, for papers by Rachel W. Miller Breakdown of academic impact, for papers by Amer Karam Breakdown of academic impact, for papers by Mike F. Janicek Breakdown of academic impact, for papers by Vicki V. Baker Breakdown of academic impact, for papers by Aliza Leiser Breakdown of academic impact, for papers by Kristin Bixel Breakdown of academic impact, for papers by Radoslav Chekerov Breakdown of academic impact, for papers by Juhani Mäenpää
Rankless by CCL
2026